Phathom Pharmaceuticals is a commercial-stage biopharmaceutical company focused on gastrointestinal diseases. Its approved products—VOQUEZNA, VOQUEZNA DUAL PAK, and VOQUEZNA TRIPLE PAK—contain vonoprazan, an oral potassium-competitive acid blocker (PCAB). VOQUEZNA is approved for Erosive GERD, Non-Erosive GERD, and H. pylori infection. All revenue is derived from U.S. sales of these three products. The company licensed vonoprazan from Takeda Pharmaceutical and began U.S. commercialization in November 2023.
Q2 FY2026 — expected 2026-08-12
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001193125-26-073379 | EDGAR | 94K words |
| 2025-03-06 | 2024-12-31 | 0000950170-25-034183 | EDGAR | 103K words |
| 2024-03-07 | 2023-12-31 | 0000950170-24-027910 | EDGAR | 105K words |
| 2023-02-28 | 2022-12-31 | 0000950170-23-004875 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0000950170-22-002536 | EDGAR | — |
| 2021-03-30 | 2020-12-31 | 0001564590-21-016682 | EDGAR | — |
| 2020-03-19 | 2019-12-31 | 0001564590-20-011712 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-07-30 | 2026-06-30 | 0001193125-26-324867 | EDGAR | 25K words |
| 2025-10-30 | 2025-09-30 | 0001193125-25-257390 | EDGAR | 26K words |
| 2025-08-07 | 2025-06-30 | 0000950170-25-104548 | EDGAR | 25K words |
| 2025-05-01 | 2025-03-31 | 0000950170-25-061440 | EDGAR | 25K words |
| 2024-11-07 | 2024-09-30 | 0000950170-24-123264 | EDGAR | 30K words |
| 2024-08-08 | 2024-06-30 | 0000950170-24-093885 | EDGAR | 27K words |
| 2024-05-09 | 2024-03-31 | 0000950170-24-056888 | EDGAR | 26K words |
| 2023-11-09 | 2023-09-30 | 0000950170-23-061554 | EDGAR | 26K words |
| 2023-08-10 | 2023-06-30 | 0000950170-23-040977 | EDGAR | 26K words |
| 2023-05-10 | 2023-03-31 | 0000950170-23-020109 | EDGAR | 24K words |
| 2022-11-08 | 2022-09-30 | 0000950170-22-023160 | EDGAR | — |
| 2022-08-02 | 2022-06-30 | 0000950170-22-013743 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-30 | 0001193125-26-324865 | EDGAR | 4K words |
| 2026-02-26 | 0001193125-26-073377 | EDGAR | 4K words |
| 2026-01-08 | 0001193125-26-007660 | EDGAR | 1K words |
| 2026-01-07 | 0001193125-26-006266 | EDGAR | 1K words |
| 2025-11-04 | 0001193125-25-263534 | EDGAR | 1K words |
| 2025-10-30 | 0001193125-25-257382 | EDGAR | 4K words |
| 2025-10-27 | 0001193125-25-250611 | EDGAR | 1K words |
| 2025-10-06 | 0001193125-25-230984 | EDGAR | 1K words |
| 2025-08-07 | 0001193125-25-174943 | EDGAR | 4K words |
| 2025-06-16 | 0001193125-25-141119 | EDGAR | 1K words |
143 total filings indexed. 114 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001783183 |
| Ticker | PHAT |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.phathompharma.com |
| Listed | 2019-10-25 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/PHAT (~200 tokens, structured JSON with cryptographic provenance)